Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CERC-501 in Stress-Precipitated Smoking Lapse
NCT02800928Phase 2Completed
- Sponsor
- Yale University
- Start
- Jun 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aticaprant in Tobacco Use Disorder (TUD), sponsored by Yale University. Started Jun 2016; status: completed.
02
Drugs
aticaprant
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT02800928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02800928.